Glycosylated albumin and serum protein in diabetic dogs.
Glycosylated albumin and glycosylated protein in serum were measured in 4 well-controlled diabetic dogs, 4 poorly controlled diabetic dogs, and 21 nondiabetic dogs. Concentrations of both glycosylated components in the well-controlled dogs were similar to those in nondiabetic dogs. Serum concentrations of glycosylated albumin and protein in the poorly controlled diabetic dogs were higher (P less than 0.001) than those of the nondiabetic and well-controlled diabetic dogs. Because of the essentially irreversible nature of the glycosylation reaction and the relatively short turnover time of albumin and other serum proteins, measurements of glycosylated serum components may provide an index of glycemia during the preceding days or weeks.
D000496:Alloxan; D000818:Animals; D001798:Blood Proteins / Q000032:analysis*; D003921:Diabetes Mellitus, Experimental / Q000097:blood* / Q000188:drug therapy; D004283:Dog Diseases / Q000097:blood* / Q000188:drug therapy; D004285:Dogs; D006442:Glycated Hemoglobin / Q000032:analysis; D017127:Glycation End Products, Advanced; D006023:Glycoproteins; D007328:Insulin / Q000627:therapeutic use; D007336:Insulin, Isophane / Q000627:therapeutic use; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D012709:Serum Albumin / Q000032:analysis*; D013311:Streptozocin; D000093422:Glycated Serum Proteins; D000093423:Glycated Serum Albumin
D000496:Alloxan; D001798:Blood Proteins; D006442:Glycated Hemoglobin; D017127:Glycation End Products, Advanced; D006023:Glycoproteins; D007328:Insulin; D007336:Insulin, Isophane; D049528:Insulin, Long-Acting; D012709:Serum Albumin; D013311:Streptozocin; D000093422:Glycated Serum Proteins; D000093423:Glycated Serum Albumin